Alessia Romito

Sassari, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Intraoperative Three-Dimensional Transvaginal Ultrasound for Hysteroscopic Metroplasty: a Controlled Study.

Intraoperative Three-Dimensional Transvaginal Ultrasound for Hysteroscopic Metroplasty: a Controlled Study.

Journal: Reproductive sciences (Thousand Oaks, Calif.)

Published: January 20, 2023

Techniques for sentinel node biopsy in breast cancer.

Techniques for sentinel node biopsy in breast cancer.

Journal: Minerva surgery

Published: August 02, 2021

New developments in rare vulvar and vaginal cancers.

New developments in rare vulvar and vaginal cancers.

Journal: Current opinion in oncology

Published: July 28, 2021

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis.

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis.

Journal: Journal of personalized medicine

Published: June 30, 2021

Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer.

Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer.

Journal: Fertility and sterility

Published: June 18, 2021

Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.

Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments.

Journal: Seminars in cancer biology

Published: May 31, 2020

Ovarian cancer treatment is evolving: more choices, more chances.

Ovarian cancer treatment is evolving: more choices, more chances.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: March 20, 2020

Modified natural cycle IVF is a reasonable alternative in women of advanced maternal age.

Modified natural cycle IVF is a reasonable alternative in women of advanced maternal age.

Journal: Reproductive biomedicine online

Published: January 23, 2020

Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates.

Heterogeneity Among Poor Ovarian Responders According to Bologna Criteria Results in Diverging Cumulative Live Birth Rates.

Journal: Frontiers in endocrinology

Published: December 27, 2019

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab.

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab.

Journal: OncoTargets and therapy

Published: February 26, 2019

Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders.

Modified natural cycle IVF versus conventional stimulation in advanced-age Bologna poor responders.

Journal: Reproductive biomedicine online

Published: February 17, 2019

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders.

Cumulative Live Birth Rates Following Stimulation With Corifollitropin Alfa Compared With hp-hMG in a GnRH Antagonist Protocol in Poor Ovarian Responders.

Journal: Frontiers in endocrinology

Published: November 22, 2018

Showing 1-12 of 26

Last Updated: 09/26/2026